Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (51-60 of 564) with videos related to

Pageof 57
Sort By:
Chest|October 7, 2018
Rebuttal From Drs Barrecheguren and MiravitllesMiriam Barrecheguren, Marc Miravitlles
Respiration; International Review of Thoracic Diseases|April 8, 2024
Genetic Epidemiology of Alpha-1 Antitrypsin Deficiency in MacaronesiaIgnacio Blanco, Marc Miravitlles
Respiratory Research|January 25, 2025
Response to: risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in contextTeresa Martín, Marc Miravitlles
American Journal of Respiratory and Critical Care Medicine|June 2, 2022
Use of Computed Tomography Lung Densitometry as an Outcome Measure for Emphysema Progression: The Case of LosartanMarc Miravitlles, Antonio Anzueto
The European Respiratory Journal|February 10, 2017
A new two-step algorithm for the treatment of COPDMarc Miravitlles, Antonio Anzueto
COPD|May 5, 2015
Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ IndividualsBeatriz Lara, Marc Miravitlles
The European Respiratory Journal|May 23, 2020
The right treatment for the right patient with COPD: lessons from the IMPACT trialDaiana Stolz, Marc Miravitlles
The American Journal of Medicine|May 20, 2018
Chronic Obstructive Pulmonary Disease Exacerbations: A Need for ActionAntonio Anzueto, Marc Miravitlles
Chest|March 11, 2018
Considerations for the Correct Diagnosis of COPD and Its Management With BronchodilatorsAntonio Anzueto, Marc Miravitlles
Pharmacoeconomics|April 28, 2005
Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literatureHelen Doll, Marc Miravitlles
Pageof 57

Showing results (51-60 of 564) with videos related to

Sort By:
Pageof 57
Chest|October 7, 2018
Rebuttal From Drs Barrecheguren and MiravitllesMiriam Barrecheguren, Marc Miravitlles
Respiration; International Review of Thoracic Diseases|April 8, 2024
Genetic Epidemiology of Alpha-1 Antitrypsin Deficiency in MacaronesiaIgnacio Blanco, Marc Miravitlles
Respiratory Research|January 25, 2025
Response to: risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in contextTeresa Martín, Marc Miravitlles
American Journal of Respiratory and Critical Care Medicine|June 2, 2022
Use of Computed Tomography Lung Densitometry as an Outcome Measure for Emphysema Progression: The Case of LosartanMarc Miravitlles, Antonio Anzueto
The European Respiratory Journal|February 10, 2017
A new two-step algorithm for the treatment of COPDMarc Miravitlles, Antonio Anzueto
COPD|May 5, 2015
Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ IndividualsBeatriz Lara, Marc Miravitlles
The European Respiratory Journal|May 23, 2020
The right treatment for the right patient with COPD: lessons from the IMPACT trialDaiana Stolz, Marc Miravitlles
The American Journal of Medicine|May 20, 2018
Chronic Obstructive Pulmonary Disease Exacerbations: A Need for ActionAntonio Anzueto, Marc Miravitlles
Chest|March 11, 2018
Considerations for the Correct Diagnosis of COPD and Its Management With BronchodilatorsAntonio Anzueto, Marc Miravitlles
Pharmacoeconomics|April 28, 2005
Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literatureHelen Doll, Marc Miravitlles
Pageof 57